Home/Filings/4/0001315406-19-000016
4//SEC Filing

HERTIA JOHN 4

Accession 0001315406-19-000016

CIK 0000012208other

Filed

Sep 12, 8:00 PM ET

Accepted

Sep 13, 11:54 AM ET

Size

14.7 KB

Accession

0001315406-19-000016

Insider Transaction Report

Form 4
Period: 2019-09-12
HERTIA JOHN
Executive Vice President
Transactions
  • Sale

    Bio-Rad A Common Stock

    2019-09-12$328.25/sh797$261,61518,769 total
  • Sale

    Bio-Rad A Common Stock

    2019-09-12$329.00/sh41$13,48918,728 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2019-09-126000 total
    Exercise: $119.54Exp: 2024-09-10Bio-Rad A Common Stock (600 underlying)
  • Exercise/Conversion

    Bio-Rad A Common Stock

    2019-09-12$119.54/sh+600$71,72418,966 total
Holdings
  • Bio-Rad A Common Stock

    (indirect: By Spouse)
    252
Footnotes (3)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $328.00 to $328.70, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]The option vests in five equal annual installments beginning September 10, 2015.
  • [F3]The option vests in five equal annual installments beginning September 11, 2016.

Issuer

BIO-RAD LABORATORIES, INC.

CIK 0000012208

Entity typeother

Related Parties

1
  • filerCIK 0001616003

Filing Metadata

Form type
4
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 11:54 AM ET
Size
14.7 KB